EPCs have significant potential in regenerative medicine and therapeutic applications. They are being explored for use in cell-based therapies to treat cardiovascular diseases, critical limb ischemia, and other conditions that require vascular repair and regeneration. Clinical trials are ongoing to assess the safety and efficacy of EPC-based treatments in various medical contexts.
